Print view
 

Studies Yield ‘Impressive’ Results in Fight Against Cystic Fibrosis

“These findings indicate that it may soon be possible to offer safe and effective molecularly targeted therapies to 90 percent of persons with cystic fibrosis,” wrote the director, Dr. Francis S. Collins, who led the team that in 1989 identified the gene that causes the genetic disease affecting the lungs and digestive system. “This should be a cause for major celebration,” he wrote in the Thursday editorial.

The two studies, published by The New England Journal of Medicine and The Lancet, describe the results of clinical trials of a three-drug therapy for people with cystic fibrosis, which causes thick mucus to build up in the lungs and other parts of the body and drastically shortens life expectancy. Both studies found that, among other things, patients who received the therapy showed improvement in a key measure of lung capacity, findings that Dr. Collins described in a separate N.I.H. blog post as “striking.”

The studies were conducted with funding from Vertex Pharmaceuticals, which developed the triple-combination drug therapy, known as Trikafta. Last week, the Food and Drug Administration approved Trikafta for use with about 90 percent of patients with cystic fibrosis — those who have the most common cystic fibrosis gene mutation and are 12 or older.

Read the full aricle here.

Autor: Niraj Chokshi   Quelle: The New York Times, 04.11.2019
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
Weitere News
‘Social recession’: how isolation can affect physical and mental health
Doctors Fear Bringing Coronavirus Home: ‘I Am Sort of a Pariah in My Family
How To Support People In Health Care Working During Coronavirus
Health officials warn US government does not have enough stockpiled medical equipment to deal with coronavirus
How infants benefit from a bilingual home
Powerful antibiotic discovered using machine learning for first time
Coronavirus COVID-19 - Live map shows spread of the virus
Powerful antibiotic discovered using machine learning for first time
'Cancer does not wait': Children's medicine shortage stokes anger in Mexico
How Technology, Medicine And At-Home Devices Can Improve Healthcare Access And Cost
Hospital Installs Sleep Pod to Help Tackle Doctors' Burnout
Evidence-based toolkit offers solutions to improve environment, health, and reduce inequalities
Catalysing Change for Gender Equality
TMW Center launches bilingual resources to advance brain development for children
Short sleep may harm bone health in older women
Human Trafficking – It Came Disguised as the Opportunity of a Lifetime
Study finds functional medicine model is associated with improvements in health-related QOL
NHS treating 5,000 diabetics a day as one in 10 patients now suffer with illness, figures reveal
Bangladesh’s Climate Change Victims Safeguard the Sundarbans’ Endangered Dolphins
A ‘Cure’ for Ebola but Will it Stop the Outbreak if People Won’t Get Treatment?
The Role of Women’s Organisations in Crisis-Settings
Statement on World Day against Trafficking in Persons
CRA shortage is worsening while demand grows – a vicious circle which opens masses of job opportunities
Why Doctors Hate Their Computers
Junior hospital doctors
90–90–90 Treatment for All
Incident Management System
Incident Management System
An Economy for the 99%
European Virus Archive goes global
Establishing a Global Vaccine-Development Fund

Newsletter Sign Up

 

AMREF - African Medical and Research FoundationAnästhesie in Entwicklungsländern e. V.Österreichisches Rotes KreuzEuropean Health Forum GasteinHelix - Forschung & Beratung WienÖsterreichische Akademie der ÄrzteCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioEuropean Public Health Association (EUPHA)